Doctors Revision

Necrosis: Mechanisms, Morphologic Patterns, Causes, Clinical Features and Complications

Necrosis

Irreversible cell and tissue injury • mechanisms • morphology • patterns • inflammation • clinical recognition • emergency implications

Necrosis is the morphologic pattern of cell or tissue death that follows severe injury and is characterised by loss of membrane integrity, enzymatic digestion of cellular components and an inflammatory response. It is most often caused by ischaemia, toxins, infection or physical injury. In modern cell-death biology, necrosis may be the final appearance of accidental destruction or of a regulated lytic pathway such as necroptosis or pyroptosis.

For emergency medicine learners, necrosis is not merely a histology term. It represents tissue that has crossed the point of no return, may release dangerous intracellular contents, and can create complications such as shock, sepsis, hyperkalaemia, compartment syndromes, organ failure and permanent loss of function.

Learning outcomes

  • Define necrosis and distinguish it from reversible cell injury and apoptosis.
  • Explain ATP depletion, calcium overload, ROS, mitochondrial failure, lysosomal digestion and membrane rupture in necrotic death.
  • Recognise nuclear changes (pyknosis, karyorrhexis and karyolysis) and cytoplasmic changes.
  • Identify coagulative, liquefactive, caseous, fat, fibrinoid and gangrenous patterns and their usual settings.
  • Explain the inflammatory consequences of DAMP release and how necrosis enlarges tissue injury.
  • Interpret clinical, laboratory, imaging and histopathology findings in common necrotic lesions.
  • Apply emergency management principles to infarction, sepsis, burns, trauma, pancreatitis, limb ischaemia and toxic injury.

1. Definition and essential features

Necrosis is cell death with structural disintegration and usually uncontrolled release of intracellular contents into the extracellular space. Four linked features are central:

  1. Irreversible energy failure: mitochondria cannot restore oxidative phosphorylation or ATP.
  2. Membrane damage: plasma, mitochondrial and lysosomal membranes lose selective permeability and rupture.
  3. Enzymatic digestion: endogenous lysosomal enzymes and sometimes leukocyte enzymes digest the dead tissue.
  4. Inflammation: DAMPs activate innate immunity, causing vascular leakage and leukocyte recruitment.
Feature Necrosis Reversible injury Apoptosis
Cell size Usually swelling (oncosis). Swelling may reverse. Shrinkage.
Membrane Severe damage and rupture. Blebs/permeability changes may recover. Intact until apoptotic-body clearance.
Nucleus Pyknosis, karyorrhexis, karyolysis and disappearance. Chromatin clumping may recover. Condensation and orderly fragmentation.
Contents Leak into tissue and blood. Remain mostly contained. Remain in membrane-bound fragments.
Inflammation Usually prominent. Minimal from the injured cell. Usually minimal.
Energy dependence Overwhelming injury and ATP failure. Energy reserve remains. Requires organised signalling and ATP.

2. Pathogenesis: from injury to necrotic tissue

2.1 Initiating insults

Ischaemia, hypoxia, toxins, infection, immune injury, heat, cold, radiation and mechanical trauma can start the cascade. The final morphology depends on dose, duration, organ, tissue architecture, presence of microbes and the speed of inflammation.

2.2 ATP depletion and failure of ion pumps

Loss of oxidative phosphorylation lowers ATP. The Na+/K+-ATPase fails, sodium and water enter, potassium leaves and the cell swells. The Ca2+ pump fails, so cytosolic calcium rises. Ribosomes detach from rough ER, protein synthesis falls and the cytoskeleton loses repair capacity.

2.3 Calcium-dependent destruction

High cytosolic Ca2+ activates phospholipases, proteases, endonucleases and ATPases. Phospholipases destroy membrane phospholipids; proteases degrade cytoskeletal proteins; endonucleases fragment DNA; ATPases consume remaining energy. Calcium also promotes mitochondrial permeability transition.

2.4 Reactive oxygen species (ROS)

Damaged mitochondria, xanthine oxidase, activated neutrophils and reperfusion generate superoxide, hydrogen peroxide and hydroxyl radicals. ROS cause lipid peroxidation, protein oxidation and DNA damage. Antioxidants such as glutathione and catalase may be overwhelmed.

2.5 Mitochondrial permeability transition

Persistent pore opening collapses the proton gradient, stops ATP production and causes mitochondrial swelling. Severe ATP failure prevents orderly apoptosis and favours necrosis. Damaged mitochondria release their own DAMPs, including mitochondrial DNA and ATP, further activating inflammation.

2.6 Lysosomal leakage and autodigestion

Lysosomal membranes become permeable. Acid hydrolases, proteases, lipases and nucleases digest cytoplasmic and nuclear structures. Inflammatory leukocytes add neutrophil proteases and ROS. Liquefaction is especially prominent when enzymatic digestion is extensive, as in brain infarction and abscesses.

2.7 Membrane rupture and DAMP release

Membrane phospholipid loss, cytoskeletal breakdown and osmotic swelling produce blebs and discontinuities. Once the membrane ruptures, intracellular enzymes and DAMPs enter the interstitium and circulation. These signals activate pattern-recognition receptors on macrophages, neutrophils and endothelial cells.

3. Morphology of necrosis

3.1 Cytoplasmic changes

  • Increased eosinophilia: RNA loss and protein denaturation make the cytoplasm intensely pink.
  • Glassy or homogeneous cytoplasm: loss of glycogen and ribosomes.
  • Vacuolation: swollen mitochondria and fragmented organelles.
  • Myelin figures: whorled phospholipid remnants of damaged membranes.
  • Cell outlines: may persist as pale “ghost cells” in coagulative necrosis or disappear completely in liquefactive necrosis.

3.2 Nuclear changes

Term Description Mechanism
Pyknosis Shrunken, intensely basophilic nucleus with dense chromatin. Chromatin condensation and DNA compaction.
Karyorrhexis Fragmentation of the pyknotic nucleus. Endonuclease-mediated DNA cleavage and mechanical fragmentation.
Karyolysis Fading and dissolution of nuclear staining. DNase digestion of chromatin.

All three changes may be seen during necrosis, often progressing from pyknosis to karyorrhexis and then karyolysis. The timing varies by organ and type of injury.

4. Patterns of necrosis

4.1 Coagulative necrosis

Coagulative necrosis is caused mainly by ischaemia in solid organs. Protein denaturation predominates over enzymatic digestion, so the basic tissue architecture remains visible for several days. Cells are eosinophilic, anucleate and appear as “ghosts.” The affected area is often firm, pale and wedge-shaped.

  • Typical organs: heart, kidney and spleen; it can occur in liver and other solid organs.
  • Classic cause: arterial infarction, except in the brain.
  • Inflammation: neutrophils enter early, followed by macrophages; later fibrosis replaces the infarct.
  • Clinical consequence: permanent loss of the infarcted functional tissue and scar formation.

4.2 Liquefactive necrosis

Liquefactive necrosis occurs when enzymatic digestion dominates. The tissue becomes soft, liquid or cystic. Neutrophils and microbial enzymes contribute in abscesses; resident microglia and lysosomes digest the dead tissue after a brain infarct.

  • Brain infarction: dead neural tissue is removed, leaving a fluid-filled cavity and gliosis.
  • Abscess: pus contains neutrophils, bacteria, necrotic debris and protein-rich fluid.
  • Clinical risk: raised intracranial pressure, mass effect, rupture into ventricles or bloodstream and sepsis.

4.3 Caseous necrosis

Caseous necrosis has a soft, friable, granular, cheese-like appearance. It is classically found in tuberculosis and some deep fungal infections within granulomas. Microscopically, the necrotic centre lacks cellular detail and is surrounded by epithelioid macrophages, Langhans-type giant cells and lymphocytes.

  • It reflects both direct microbial injury and a cell-mediated immune response.
  • The lesion may heal by fibrosis and calcification or progress, cavitate and spread.
  • Acid-fast or fungal stains, cultures and molecular tests establish the cause; appearance alone is not sufficient.

4.4 Fat necrosis

Fat necrosis is destruction of adipocytes with release of triglycerides and free fatty acids. In pancreatitis, pancreatic lipases digest peripancreatic fat; fatty acids bind calcium to form chalky white calcium soaps (saponification). Traumatic fat necrosis can occur in breast, subcutaneous tissue or marrow and may mimic a tumour.

  • Biochemistry: severe saponification can lower serum calcium and contribute to tetany or arrhythmia.
  • Imaging: ultrasound, CT and mammography may show calcified or mass-like lesions.
  • Management: treat the underlying pancreatitis or injury and investigate persistent masses appropriately.

4.5 Fibrinoid necrosis

Fibrinoid necrosis occurs mainly in vessel walls during immune-mediated injury or severe hypertension. Plasma proteins, fibrin and immune complexes deposit in the wall, producing a bright eosinophilic “fibrinoid” appearance.

  • Examples: polyarteritis nodosa, immune-complex vasculitis, malignant hypertension and pre-eclampsia-related vascular injury.
  • Consequences: thrombosis, aneurysm, haemorrhage or downstream ischaemia.
  • Diagnosis: requires vessel biopsy and correlation with serology, renal findings and systemic symptoms.

4.6 Gangrenous necrosis

Gangrene is a clinical term rather than a separate microscopic mechanism. It describes extensive ischaemic necrosis of a limb, bowel or other tissue. Dry gangrene is predominantly coagulative and mummified; wet gangrene adds bacterial infection, oedema and liquefaction; gas gangrene is myonecrosis with gas-forming organisms, especially Clostridium.

Type Appearance and mechanism Emergency clues
Dry gangrene Cold, dry, shrivelled, demarcated black tissue from chronic arterial insufficiency. Absent pulses, rest pain, tissue loss; urgent vascular assessment.
Wet gangrene Oedematous, infected, foul, rapidly spreading necrosis. Fever, toxicity, crepitus, bullae, hypotension; urgent antibiotics and surgical source control.
Gas gangrene Rapid clostridial myonecrosis with gas, toxins and severe pain. Pain out of proportion, systemic toxicity, haemolysis, shock; immediate surgery, antibiotics and resuscitation.
Fournier gangrene Necrotising infection of perineal and genital fascia. Severe pain, swelling, crepitus or skin changes; emergency debridement and broad-spectrum therapy.

5. Necrosis and inflammation

5.1 DAMPs

Necrotic cells release damage-associated molecular patterns (DAMPs), including extracellular ATP, HMGB1, mitochondrial DNA, uric acid, heat-shock proteins and cytosolic proteins. These activate toll-like receptors, NOD-like receptors, inflammasomes and complement.

5.2 Local response

  1. Damaged endothelium and macrophages release cytokines such as TNF, IL-1 and IL-6.
  2. Arterioles dilate and microvascular permeability rises.
  3. Neutrophils migrate toward the lesion and release ROS, proteases and extracellular traps.
  4. Macrophages clear debris; resolution, abscess formation or fibrosis follows.

5.3 Systemic response

Extensive necrosis can produce fever, leukocytosis, acute-phase protein elevation and shock. DAMPs may synergise with pathogen-associated molecular patterns in sepsis. Massive cell breakdown releases potassium, phosphate, urate, myoglobin and inflammatory mediators. Tumour lysis, rhabdomyolysis and crush injury demonstrate how necrosis can become a systemic metabolic emergency.

6. Causes and clinical examples

Cause Necrotic lesion Important clinical setting
Arterial occlusion Coagulative infarction. Myocardial infarction, renal/splenic infarct, acute limb ischaemia.
Venous obstruction or strangulation Haemorrhagic infarction, wet gangrene. Volvulus, incarcerated hernia, ovarian/testicular torsion.
Infection Liquefactive abscess, caseous necrosis, myonecrosis. Sepsis, tuberculosis, necrotising fasciitis.
Toxins Patchy or zonal organ necrosis. Paracetamol hepatotoxicity, cyanide, corrosive ingestion.
Physical trauma Crush-related muscle necrosis, fat necrosis, burns. Road traffic injury, compartment syndrome, electrical burns.
Immune/vascular injury Fibrinoid necrosis, infarction. Vasculitis, malignant hypertension, transplant rejection.
Pancreatic enzymes Fat necrosis and pancreatic tissue necrosis. Severe acute pancreatitis.

7. Organ-specific necrosis

7.1 Myocardial infarction

  • Myocytes develop coagulative necrosis after sustained coronary occlusion.
  • Neutrophils enter during the first few days; macrophages remove dead tissue; granulation tissue and a collagen scar follow.
  • Complications include arrhythmia, acute heart failure, cardiogenic shock, papillary muscle rupture, ventricular septal rupture, free-wall rupture and pericarditis.
  • Troponin and ECG changes identify myocardial injury/ischaemia; urgent reperfusion is the time-critical intervention.

7.2 Brain infarction

  • Neurons are highly vulnerable to ATP failure; excitotoxic glutamate and calcium overload amplify injury.
  • Liquefactive necrosis develops as microglia and macrophages digest the infarct.
  • Oedema, raised intracranial pressure, herniation and haemorrhagic transformation can threaten life.
  • Time-sensitive reperfusion, airway protection, glucose/temperature management and stroke-unit care are essential.

7.3 Renal cortical or tubular necrosis

  • Ischaemia and toxins can cause acute tubular injury and, if severe, necrosis.
  • Findings include oliguria, rising creatinine, hyperkalaemia, acidosis and urinary casts.
  • Manage shock, remove nephrotoxins, adjust doses and treat life-threatening electrolyte disorders.

7.4 Liver necrosis

  • Hypoxic hepatitis, viral injury, toxins and autoimmune disease can produce centrilobular or massive necrosis.
  • AST/ALT may reach very high levels, but synthetic failure (INR, glucose, encephalopathy) determines urgency.
  • Paracetamol overdose requires immediate risk assessment and N-acetylcysteine when indicated; do not wait for severe transaminase elevation.

7.5 Pancreatic and peripancreatic necrosis

  • Activated pancreatic enzymes digest pancreatic and fat tissue.
  • Systemic inflammatory response, hypocalcaemia, shock, respiratory failure and infected necrosis can develop.
  • Early supportive care, fluid assessment, analgesia, nutrition and specialist imaging/intervention are required; antibiotics are not a substitute for source control when infected necrosis is present.

8. Diagnosis

8.1 History and examination

  • Identify timing, vascular risk, trauma, exposure, infection, surgery, autoimmune disease and immunosuppression.
  • Look for pain out of proportion, absent pulses, coldness, demarcation, crepitus, bullae, foul discharge or rapidly progressive swelling.
  • Assess systemic toxicity: fever or hypothermia, tachycardia, hypotension, confusion, oliguria and respiratory distress.

8.2 Laboratory tests

Test Why it helps Caveat
Full blood count/CRP Inflammation, infection, anaemia. Non-specific and may be normal early.
Lactate, blood gas Tissue hypoperfusion, acidosis and shock severity. Not a direct measure of dead tissue.
Troponin/CK-MB Myocardial injury. Requires clinical and ECG correlation.
AST/ALT, bilirubin, INR, glucose Hepatocellular injury and liver synthetic failure. Enzyme release may precede or outlast actual necrotic burden.
CK, potassium, phosphate, calcium, urate, creatinine Rhabdomyolysis, crush injury and tumour-lysis-like metabolic complications. Trend rapidly in severe injury.
Blood cultures and tissue cultures Identify infection and guide therapy. Do not delay time-critical antibiotics in a septic patient.

8.3 Imaging and pathology

  • Doppler/CT angiography: arterial occlusion, limb ischaemia and bowel perfusion.
  • Ultrasound/CT: abscess, gas, pancreatic necrosis, torsion and fluid collections.
  • CT/MRI brain: infarct, oedema, haemorrhage and mass effect.
  • Histology: confirms pattern and may reveal granulomas, vasculitis, organisms or tumour.
  • Microbiology and special stains: required for tuberculosis, fungi and unusual infections.

9. Emergency management principles

  1. Resuscitate: airway, breathing, circulation, oxygenation, glucose, temperature and monitoring.
  2. Restore perfusion: treat shock, activate stroke/acute coronary/acute limb ischaemia pathways and relieve obstruction or compartment pressure.
  3. Control infection: administer appropriate empiric antimicrobials when sepsis or necrotising infection is suspected; obtain cultures without dangerous delay.
  4. Source control: urgent surgical review for debridement, drainage, fasciotomy, amputation or relief of strangulation/torsion.
  5. Manage metabolic release: monitor and treat hyperkalaemia, acidosis, hypocalcaemia, hyperphosphataemia, hyperuricaemia and myoglobin-associated kidney injury.
  6. Stop toxins and use antidotes: identify exposures, contact poison services and give specific therapy when indicated.
  7. Support failing organs: ventilation, vasopressors, renal replacement therapy and nutritional support may be required.
  8. Reassess repeatedly: necrosis can progress beyond its initial border; serial examinations and laboratory trends are essential.

Red flags for necrotising soft-tissue infection

  • Pain out of proportion to visible skin findings.
  • Rapid progression of swelling, erythema, dusky skin, bullae or skin anaesthesia.
  • Crepitus, foul discharge, systemic toxicity, hypotension or confusion.
  • High-risk host: diabetes, immunosuppression, peripheral vascular disease, recent surgery or trauma.

Do not wait for a normal early x-ray or a dramatic laboratory score. Resuscitation, broad empiric antibiotics, urgent surgical consultation and source control are time-critical.

10. Complications of necrosis

Complication Mechanism Example
Inflammatory injury DAMPs, cytokines, neutrophil ROS and proteases injure surrounding viable cells. Peri-infarct inflammation or sepsis.
Abscess/cavity formation Liquefaction and incomplete drainage leave a collection. Brain or liver abscess.
Fibrosis and contracture Macrophage clearance followed by collagen deposition. Post-infarct myocardial scar.
Calcification Calcium deposits in dead tissue (dystrophic calcification). Old tuberculosis or fat necrosis.
Shock and organ failure Loss of vascular/tissue function and systemic cytokine response. Septic or cardiogenic shock.
Metabolic catastrophe Release of potassium, phosphate, urate, myoglobin and acids. Crush syndrome or tumour lysis.
Rupture/haemorrhage Structural weakening during tissue digestion. Cardiac free-wall rupture or vessel necrosis.

11. Applied cases

Case 1: Acute limb ischaemia

A patient develops sudden severe leg pain, pallor, pulselessness, paraesthesia and weakness. The likely cause is arterial occlusion with threatened muscle and nerve. Give immediate analgesia, anticoagulation if appropriate, urgent vascular review and reperfusion assessment. Delay permits irreversible muscle necrosis and raises the risk of compartment syndrome and reperfusion-related hyperkalaemia.

Case 2: Necrotising fasciitis

A diabetic patient has severe pain after a minor wound, rapidly spreading oedema, bullae and shock. The necrotic pattern is infection-driven lytic destruction with toxin, vascular thrombosis and inflammatory amplification. Resuscitation, broad-spectrum antibiotics and immediate surgical exploration/debridement must proceed in parallel.

Case 3: Acute pancreatitis

Pancreatic lipases produce fat necrosis and calcium saponification; severe disease can cause pancreatic parenchymal necrosis, systemic inflammation and organ failure. Monitor oxygenation, urine output, electrolytes, glucose, calcium and haemodynamics while obtaining specialist input.

12. Necrosis versus regulated lytic death

Question Necrosis (morphology) Necroptosis / pyroptosis (mechanism)
What is it? Observed tissue pattern: swelling, digestion, rupture and inflammation. Signalling programmes that intentionally execute lytic death.
Can it follow severe ischaemia? Yes. Yes, especially if apoptosis is blocked or innate sensors are activated.
Is inflammation expected? Usually. Usually, because membranes rupture and cytokines/DAMPs are released.
Does the name identify the cause? No; history and tests are required. It identifies a molecular route but still requires clinical context.

13. Quick self-test

  1. What are the four defining features of necrosis?
    Answer: Irreversible energy failure, membrane damage/rupture, enzymatic digestion and inflammation.
  2. Which necrosis pattern is typical of a myocardial infarct?
    Answer: Coagulative necrosis.
  3. Why does a brain infarct undergo liquefactive necrosis?
    Answer: Enzymatic digestion by microglia and macrophages removes the soft neural tissue.
  4. What causes chalky deposits in pancreatic fat necrosis?
    Answer: Free fatty acids bind calcium to form soaps (saponification).
  5. Name the three nuclear changes of necrosis.
    Answer: Pyknosis, karyorrhexis and karyolysis.
  6. Why can necrosis cause hyperkalaemia?
    Answer: Ruptured cells release intracellular potassium into tissue and blood, especially when a large muscle mass is injured.
  7. What red flag should prompt urgent assessment for necrotising soft-tissue infection?
    Answer: Pain out of proportion with rapid progression, systemic toxicity, bullae, crepitus or skin anaesthesia.
  8. What is the treatment principle for established necrosis?
    Answer: Remove or control the cause, salvage threatened tissue, debride/drain non-viable tissue when indicated and support failing organs.

14. Take-home summary

  • Necrosis is a lytic, usually inflammatory pattern of irreversible cell and tissue death.
  • ATP failure, calcium overload, ROS, mitochondrial permeability transition, lysosomal digestion and membrane rupture drive the process.
  • Pyknosis, karyorrhexis and karyolysis are the classic nuclear changes.
  • Recognise coagulative, liquefactive, caseous, fat, fibrinoid and gangrenous patterns and their clinical contexts.
  • DAMP release can produce inflammation, systemic shock and secondary injury beyond the original lesion.
  • Emergency treatment focuses on rapid resuscitation, reperfusion when indicated, antidotes, antimicrobials, source control, debridement and metabolic support.

Selected references

Educational note: This resource supports learning and clinical reasoning. Current local protocols, senior supervision and national guidelines take precedence in patient care.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top